跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tazocin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tazocin
Approved
STANDARD
Tazocin
Wyeth Lederle S.r.L
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
40ab6605b4d57035
Company
Wyeth Lederle S.r.L
Type
Standard
Approval Details
Approval Id
40ab6605b4d57035
Drug Approval Philippines Name
Tazocin
Product Name
Tazocin
Registration Number
DR-XY39441
Brand Name
Tazocin
Generic Name
Piperacillin (as Sodium ) + Tazobactam (as Sodium)
Dosage Form
Lyophilized Powder for I.V. Injection
Dosage Strength
2 g/ 250 mg
Manufacturer
Wyeth Lederle S.r.L
Importer
Pfizer, Inc.
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
26 April 2021
Expiry Date
30 June 2026
Pharmacologic Category
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
40ab6605b4d57035
Type
Standard
Back to Philippines FDA Approvals